Search - tctmd.com

Displaying 501 - 520 of 1180

Sort: Relevancy | Date

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Conference News

Wrong BP Cuff Size May Lead to Wildly Inaccurate Readings

L.A. McKeown

March 02, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Financial Strain Ups Risk of Death After Acute MI in the Elderly

L.A. McKeown

February 25, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Yael L. Maxwell

February 09, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

Caitlin E. Cox

January 31, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking

Todd Neale

January 25, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

Advertisement

Guideline-Directed Therapies Underused in Frail HF Patients

Wrong BP Cuff Size May Lead to Wildly Inaccurate Readings

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

March 2022 News Roundup

Financial Strain Ups Risk of Death After Acute MI in the Elderly

FDA Approves Empagliflozin for Treatment of HFpEF

Fewer Diabetic Complications Seen When NOACs Given for AF

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

February 2022 News Roundup

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content